Have they in the past talked about or guided to any other ANDA(not new FOB pathway) in next 2-3 years (of course other than copaxone)? it could be a generic for a biologic approved using new drug pathway like lovenox
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.